Search results for: Chronic Diseases
Filter search results
Pharmaceutical Industry and Society: a Study of the Changing Environment and Economics of the International Industry
1 July 1972
…instance, has basically altered demographic patterns; the virtual elimination in some areas of malaria and other tropical diseases has caused a population explosion; that is to say the environmental and…
Cystic Fibrosis
1 March 1986
…confusion with other diseases for a considerable period of time. The first year that cystic fibrosis (or cystic fibrosis of the pancreas as it was then called) was distinguished from…
Measuring Health: a Practical Approach
7 January 1988
…patients as cases of diseases and categorize them as so, and then treat them by computer-directed regimens—a sad reflection of the profession’s willingness to accept modern technology and start to…
Born Imperfect: The role of genetic disease
1 January 1993
…(RCP London, 1989). Progressively infectious and nutritional diseases have been effectively controlled or eliminated in the Western world and poor social and environmental conditions ameliorated. Inevitably, and in contrast, genetic…
Deep Vein Thrombosis and Pulmonary Embolism
10 January 1996
…of deep vein thrombosis and the therapeutic and prophylactic measures available to treat and prevent venous thromboembolic diseases have increased, it continues to be of great importance in surgery today…
Eleanor Bell
16 September 2019
Eleanor is an economist specialising in the modelling and evaluation of healthcare interventions for infectious diseases.She works at the UK Health Security Agency, where she leads the agency’s economic analysis…
Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
11 April 2023
…also find variation across disease areas, with carer burden more likely to be considered in disease areas with higher intensity and longer duration of care needs, particularly neurodegenerative diseases and…
The US Inflation Reduction Act: What Do the Experts Think?
25 May 2023
…and for rare diseases. Also, several mentioned that launch prices may rise, as companies try to compensate for losses they will make at the end of the product lifecycle. In…
Stuart Carroll
30 August 2023
Stuart Carroll is a senior health economist and epidemiologist with over 22 years of experience, specialising in infectious diseases and vaccines, market access, health technology appraisal, public health, and public…